ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

1,6-ジヒドロ-1-メチル-6-オキソ-3-ピリジンカルボアミド

N1-Methyl-2-pyridone-5-carboxamide

HCID 69698
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
701-44-0
標準SMILES
Cn1cc(C(N)=O)ccc1=O
InChIKey
JLQSXXWTCJPCBC-UHFFFAOYSA-N
分子式
C7H8N2O2
平均分子量
152.15 g/mol
単同位体質量
152.0585775

概要

N-methyl-6-pyridone-3-carboxamide is a pyridone that is 2-pyridone substituted with a carboxamide group at C-5 and a methyl group at N-1. It has a role as a metabolite and a mouse metabolite. It is a member of methylpyridines, a pyridinecarboxamide and a pyridone.

名称と識別子

優先名称
N1-Methyl-2-pyridone-5-carboxamide
IUPAC
1-methyl-6-oxopyridine-3-carboxamide
現地名
1,6-ジヒドロ-1-メチル-6-オキソ-3-ピリジンカルボアミド
英語名
1-methyl-6-oxo-pyridine-3-carboxamide
分子式
C7H8N2O2
分子量
152.15

名称と別名

Nudifloramide701-44-01-methyl-6-oxo-1,6-dihydropyridine-3-carboxamideN1-Methyl-2-pyridone-5-carboxamideN'-Methyl-2-pyridone-5-carboxamide1-Methyl-5-carboxylamide-2-pyridone3-Pyridinecarboxamide, 1,6-dihydro-1-methyl-6-oxo-DTXSID7022037468139USC7WN(1)-methyl-2-pyridone-5-carboxamideRefChem:831461DTXCID70142865
名称をさらに表示
1-メチル-6-オキソ-1,6-ジヒドロニコチンアミド1-メチル-2-オキソ-1,2-ジヒドロ-5-ピリジンカルボアミド1,6-ジヒドロ-1-メチル-6-オキソ-3-ピリジンカルボアミド1,2-ジヒドロ-1-メチル-2-オキソピリジン-5-カルボキサミド1-メチル6-オキソ-1,6-ジヒドロ-3-ピリジンカルボアミド1-メチル-2-ピリドン-5-カルボキサミド1-メチル-5-カルバモイル-2(1H)-ピリドン1,6-ジヒドロ-1-メチル-6-オキソピリジン-3-カルボアミド1-メチル-2-オキソ-1,2-ジヒドロピリジン-5-カルボアミド1-メチル-1,2-ジヒドロ-2-オキソピリジン-5-カルボアミド1-メチル-6-オキソ-1,6-ジヒドロピリジン-3-カルボアミドN1-メチル-2-ピリドン-5-カルボキサミド1-メチル-1,6-ジヒドロ-6-オキソピリジン-3-カルボアミドヌジフロルアミド1,2-ジヒドロ-1-メチル-2-オキソ-5-ピリジンカルボアミド1,2-ジヒドロ-1-メチル-2-オキソピリジン-5-カルボアミド1-メチル-6-オキソ-1,6-ジヒドロピリジン-3-カルボキサミドヌジフロラミドN1-メチル-2-ピリドン-5-カルボアミド2-PyN-methyl-6-pyridone-3-carboxamide

物性

構造計算による物性

XLogP
-1
極性表面積
63.4 Ų
水素結合供与体数
1
水素結合受容体数
2
回転可能結合数
1
重原子数
11
形式電荷
0
複雑度
266

実験および物理化学的性質

Physical DescriptionSolid
Collision Cross Section132.1 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

物理化学的性質

融点
202 · 202-207°C (dec.)
沸点
396.7 · 396.7±42.0 °C(Predicted)
比重(密度)
1.3 · 1.300±0.06 g/cm3(Predicted)
貯蔵温度
Sealed in dry,Room Temperature
溶解性
DMSO(微量)、メタノール(微量、加温)
外見
個体
酸解離定数(Pka)
14.46 · 14.46±0.20(Predicted)
色
白から薄茶色
InChI
1S/C7H8N2O2/c1-9-4-5(7(8)11)2-3-6(9)10/h2-4H,1H3,(H2,8,11)
InChIKey
JLQSXXWTCJPCBC-UHFFFAOYSA-N
SMILES
[n]1([c](ccc(c1)C(=O)N)=O)C

化学的性質

化学的特性Light Brown Solid

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Warning

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

P260, P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 4 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Hazard Classes and CategoriesSkin Irrit. 2 (100%)

毒性情報

TreatmentKidney dialysis is usually needed to relieve the symptoms of uremic syndrome until normal kidney function can be restored.
Health EffectsChronic exposure to uremic toxins can lead to a number of conditions including renal damage, chronic kidney disease and cardiovascular disease.
Exposure RoutesEndogenous, Ingestion, Dermal (contact)
Toxicity Summary · 1 件

Uremic toxins such as N-methyl-2-pyridone-5-carboxamide are actively transported into the kidneys via organic ion transporters (especially OAT3). Increased levels of uremic toxins can stimulate the production of reactive oxygen species. This seems to be mediated by the direct binding or inhibition by uremic toxins of the enzyme NADPH oxidase (especially NOX4 which is abundant in the kidneys and heart) (A7868). Reactive oxygen species can induce several different DNA methyltransferases (DNMTs) which are involved in the silencing of a protein known as KLOTHO. KLOTHO has been identified as having important roles in anti-aging, mineral metabolism, and vitamin D metabolism. A number of studies have indicated that KLOTHO mRNA and protein levels are reduced during acute or chronic kidney diseases in response to high local levels of reactive oxygen species (A7869).

化学と産業

薬理情報

Metabolism/MetabolitesUremic toxins tend to accumulate in the blood either through dietary excess or through poor filtration by the kidneys. Most uremic toxins are metabolic waste products and are normally excreted in the urine or feces.
Tissue LocationsPlacenta
Cellular LocationsCytoplasm
Metabolite PathwaysNicotinate and nicotinamide metabolism

用途と製造

UsesNaturally produced by the body (endogenous).
応用分野 · 1 件

説明Nudifloramide, known more commonly as N-methyl-2-pyridone-5-carboxamide (2-Py), is a metabolite of niacin via nicotinamide. It can be measured in serum and urine as part of metabolomic studies of niacin or nicotinamide intake and usage. Circulating levels of nudifloramide can be elevated and associated with toxic effects in patients receiving supplemental nicotinamide.

上流・下流製品情報

上流原料

1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid ethyl esterメタノールアンモニア

補足説明

ChEBI: A pyridone that is 2-pyridone substituted with a carboxamide group at C-5 and a methyl group at N-1.

関連反応

0 件
反応記録を作成
関連する反応はまだありません

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
1-Methyl-6-oxo-1,6-dihydronicotinamide
Nicotinamide Impurity 6(Nedifloramide)
1-Methyl 6-oxo-1,6-dihydro-3-pyridinecarboxamide
1-methyl-6-oxopyridine-3-carboxamideN-methyl-2-pyridone-5-carboxamideMFCD004572831-METHYL-6-OXO-PYRIDINE-3-CARBOXAMIDE2PY3-Carbamoyl-1-methyl-6-pyridoneN-Me-2PY1,6-Dihydro-1-methyl-6-oxonicotinamide

データベース識別子

CAS
701-44-0
PubChem CID
69698
DTXSID
DTXSID70220374
ChEMBL
CHEMBL3542314
ChEBI
CHEBI:27410
UNII
68139USC7W
EC Number
977-620-1
Nikkaji
J121.846H
Signs and Symptoms · 1 件

As a uremic toxin, this compound can cause uremic syndrome. Uremic syndrome may affect any part of the body and can cause nausea, vomiting, loss of appetite, and weight loss. It can also cause changes in mental status, such as confusion, reduced awareness, agitation, psychosis, seizures, and coma. Abnormal bleeding, such as bleeding spontaneously or profusely from a very minor injury can also occur. Heart problems, such as an irregular heartbeat, inflammation in the sac that surrounds the heart (pericarditis), and increased pressure on the heart can be seen in patients with uremic syndrome. Shortness of breath from fluid buildup in the space between the lungs and the chest wall (pleural effusion) can also be present.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

安全データ

wgk
WGK 3
hs_code
2933399090
ストレージクラス
11 - Combustible Solids
定義